FTRE Similar Chart Price Prediction
The price of FTRE is predicted to go up 46.73%, based on the high correlation periods with TSVT. The similarity of these two price pattern on the periods is 98.35%.
FTRE
TSVT
Up: 46.73%Similarity: 98.35%
FTRE Revenue Forecast
FTRE EPS Forecast
FTRE FAQs
What is bull’s view on FTRE?
What is bear's view on FTRE?
What is FTRE revenue forecast for next quarter？
What is FTRE eps forecast for next quarter？
FTRE VS S&P500
Fortrea is poised to benefit from steadily increasing levels of outsourced clinical trials and complex novel therapeutics, such as biologics and gene therapies.
Fortrea has extensive experience across 20 therapeutic areas across every phase of the development from clinical pharmacology to phase 4 studies conducted post-approval.
Fortrea has a large global footprint with operations in 90 countries, which is beneficial when running late-stage, multinational clinical trials.
FTRE Analyst's Forecast
Patrick Donnelly
Citigroup
Strong Buy → Hold
2024-12-11
Price Target
$30 → $23
Upside
+18.25%
Citi downgraded Fortrea to Neutral from Buy with a price target of $23, down from $30. The firm says it has less clarity on the company's margin story in a more challenged bookings backdrop. Fortrea's overall visibility in the current environment brings more uncertainty on management's constructive view on Q1 bookings, the analyst tells investors in a research note.
Eric Coldwell
Baird
Buy → Hold
2024-12-06
Price Target
$28 → $25
Upside
+15.37%
Charles Rhyee
TD Cowen
Hold
2024-11-11
Price Target
$23 → $25
Upside
+9.89%
